Characteristics of subjective cognitive decline associated with amyloid positivity
Introduction The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid
Sin categoría
Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes
Physical mobility is essential to health, and patients often rate it as a high-priority clinical
Uncertainty of MR-PET image registration is mainly driven by the quality of PET images
Accurate regional brain quantitative PET measurements, particularly when using partial volume correction, rely on robust
Conducting public involvement in dementia research
Dementia outcomes include memory loss, language impairment, reduced quality of life and personality changes. Research
Enabling monitoring of health status, disease progression & evaluation of interventions in real-world situations
Digital mobility assessment using wearable sensor systems has the potential to capture walking performance in
Study finds that Kininogen-1 levels in CSF may serve as a marker of cognitive impairment in Parkinson’s disease
Cognitive impairment is common in patients with Parkinson’s disease (PD). Core markers of Alzheimer’s dementia
ADDI celebrates one year of achievements
On 17 November 2020, a coalition of partners including the US Alzheimer’s Association, Gates Ventures
Investigating CD33 & TREM2 as potential drug targets on microglia to clear amyloid beta & keep tissue homeostasis
Deletion of Alzheimer’s disease-associated CD33 results in an inflammatory human microglia phenotype Genome-wide association studies
Demonstrating the usefulness of a two-stage approach in characterising the evolution of correlated cognitive and clinical outcomes
A key challenge for the secondary prevention of Alzheimer’s dementia is the need to identify
Mobilise-D links with Voice Global to promote global patient engagement
Mobilise-D is now using the Voice Global platform as part of their Patient and Public